top of page
Browse by category
Search
Gastric bypass associated with a lower incidence of MACE vs. sleeve gastrectomy over an 11-year follow-up
Gastric bypass (GB) is associated with a lower incidence of major adverse cardiac events (MACE) compared to sleeve gastrectomy (SG) over...
Long-term effectiveness of gastric bypass in treating type 2 diabetes and obesity
Roux-en-Y gastric bypass kept type 2 diabetes in remission for up to 15 years and most of the weight off for up to 20 years in one of the...
Gastric bypass improves long-term T2DM remission even after weight recurrence
Adults who have obesity and type 2 diabetes are much more likely to see their diabetes stay in remission if they undergo gastric bypass...
Concentration of metabolites and fats return one year after gastric bypass
The biggest metabolic changes after gastric bypass happen directly after surgery and just one year after the operation, the concentration...
Ceramide levels predict T2DM remission following RYGB
Levels of ceramides can also be used to assess the likelihood that a gastric bypass patient will have a recurrence of type 2 diabetes...
Bypass patients maintain 20% weight loss vs 5% non-surgical
Surgical vs non-surgical outcomes - Weight loss was maintained better after gastric bypass than after sleeve gastrectomy and non-surgical...
The advantages of MGB, Diverted-MGB and banded-MGB
The popularity of mini gastric bypass (MGB) has increased in recent years as a simpler, yet safe and effective alternative to roux en y...
Browse by tag
bottom of page